bioMérieux
ISIN: FR0013280286 | Ticker: BIM | LEI: 549300AK8Y0LBIQ4T071
Country: France
Dedicated to solving some of today’s biggest public health challenges, bioMérieux has the focus and the capabilities to discover, develop, and commercialize advanced medical diagnostics solutions that have an impact on people’s lives. We combine the dynamism of a technology-fueled company with the long-term thinking of our founding family. It is this alliance that shapes our strategy and success.
A values-based company, we aim for strong and sustainable performance that benefits our shareholders, our employees, and society.
1963
Served areaWorldwide
Headcount10,400
Headquarters376 Chemin de l'Orme, 69280 Marcy l'Etoile – France
| Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Assets | 3,927,800,000.00 | 4,605,000,000.00 | 5,186,600,000.00 |
| Noncurrent Assets | 2,266,300,000.00 | 2,412,500,000.00 | 2,969,900,000.00 |
| Property Plant And Equipment | 939,000,000.00 | 1,100,800,000.00 | 1,250,300,000.00 |
| Goodwill | 629,400,000.00 | 669,500,000.00 | 812,500,000.00 |
| Intangible Assets Other Than Goodwill | 430,700,000.00 | 411,500,000.00 | 625,000,000.00 |
| Investment Accounted For Using Equity Method | 0.00 | 900,000.00 | 900,000.00 |
| Deferred Tax Assets | 72,600,000.00 | 32,000,000.00 | 58,700,000.00 |
| Noncurrent Finance Lease Receivables | 14,300,000.00 | 12,600,000.00 | 12,900,000.00 |
| Current Assets | 1,661,600,000.00 | 2,184,600,000.00 | 2,216,700,000.00 |
| Other Current Receivables | 82,200,000.00 | 117,800,000.00 | 152,600,000.00 |
| Cash and cash equivalents | 389,200,000.00 | 803,500,000.00 | 552,600,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | 0.00 | 8,000,000.00 | 0.00 |
| Other Current Assets | 8,000,000.00 | 9,500,000.00 | 16,300,000.00 |
| Equity And Liabilities | 3,927,800,000.00 | 4,605,000,000.00 | 5,186,600,000.00 |
| Equity | 2,481,300,000.00 | 3,163,600,000.00 | 3,642,900,000.00 |
| Issued Capital | 12,000,000.00 | 12,000,000.00 | 12,000,000.00 |
| Retained Earnings Profit Loss For Reporting Period | 404,400,000.00 | 601,100,000.00 | 452,400,000.00 |
| Share Premium | N/A | 63,700,000.00 | 74,000,000.00 |
| Other Reserves | N/A | 1,211,100,000.00 | 1,094.00 |
| Equity Attributable To Owners Of Parent | 2,431,100,000.00 | 3,112,200,000.00 | 3,604,200,000.00 |
| Noncontrolling Interests | 50,200,000.00 | 51,400,000.00 | 38,700,000.00 |
| Noncurrent Liabilities | 522,700,000.00 | 485,600,000.00 | 412,500,000.00 |
| Noncurrent Provisions | 64,400,000.00 | 62,500,000.00 | 41,100,000.00 |
| Deferred Tax Liabilities | 105,800,000.00 | 60,300,000.00 | 53,000,000.00 |
| Current Liabilities | 923,800,000.00 | 955,800,000.00 | 1,131,100,000.00 |
| Current Provisions | 51,400,000.00 | 51,500,000.00 | 42,100,000.00 |
| Other Current Payables | 451,700,000.00 | 448,500,000.00 | 507,900,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | 0.00 | 0.00 | 0.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 3,118,200,000.00 | 3,376,200,000.00 | 3,589,100,000.00 |
| Profit Loss From Operating Activities | 552,800,000.00 | 784,300,000.00 | 587,200,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -200,000.00 | -700,000.00 | 0.00 |
| Income Tax Expense Continuing Operations | 121,500,000.00 | 175,600,000.00 | 140,100,000.00 |
| Profit (loss) | 402,700,000.00 | 598,200,000.00 | 440,500,000.00 |
| Profit Loss Attributable To Owners Of Parent | 404,400,000.00 | 601,100,000.00 | 452,400,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | -1,700,000.00 | -2,900,000.00 | -11,800,000.00 |
| Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 402,700,000.00 | 598,200,000.00 | 440,500,000.00 |
| Adjustments For Income Tax Expense | -121,500,000.00 | -175,600,000.00 | -140,100,000.00 |
| Adjustments For Decrease Increase In Inventories | 82,900,000.00 | 48,800,000.00 | 92,100,000.00 |
| Adjustments For Decrease Increase In Other Operating Receivables | -500,000.00 | -2,700,000.00 | -500,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | -4,700,000.00 | -24,200,000.00 | -9,900,000.00 |
| Adjustments For Depreciation And Amortisation Expense | -210,800,000.00 | -189,000,000.00 | -210,000,000.00 |
| Adjustments For Provisions | 16,300,000.00 | -2,300,000.00 | -17,000,000.00 |
| Adjustments For Sharebased Payments | 9,900,000.00 | 12,400,000.00 | 13,000,000.00 |
| Adjustments For Fair Value Gains Losses | 600,000.00 | 400,000.00 | 900,000.00 |
| Adjustments For Undistributed Profits Of Associates | 200,000.00 | 700,000.00 | 0.00 |
| Other Adjustments To Reconcile Profit Loss | -19,100,000.00 | 7,700,000.00 | -11,600,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | -115,900,000.00 | -185,400,000.00 | -223,500,000.00 |
| Cash Flows From Used In Operating Activities | 582,800,000.00 | 824,700,000.00 | 475,100,000.00 |
| Cash Flows From Used In Investing Activities | -265,200,000.00 | -307,300,000.00 | -528,100,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | 18,400,000.00 | 17,400,000.00 | 157,200,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | 292,000,000.00 | 18,200,000.00 | 67,700,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 426,500,000.00 | 68,300,000.00 | 53,400,000.00 |
| Cash Flows From Used In Financing Activities | -176,200,000.00 | -140,600,000.00 | -244,200,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 376,800,000.00 | -297,200,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -34,100,000.00 | 39,200,000.00 | 38,700,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 141,400,000.00 | 376,800,000.00 | N/A |
| Cash and cash equivalents | 389,200,000.00 | 803,500,000.00 | 552,600,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 04.09.23 | None | Other | Sell | EUR 137,517.82 |
| 04.09.23 | None | Other | Sell | EUR 120,328.10 |
| 01.09.23 | None | Other | Other | EUR 0.00 |
| 23.06.23 | None | Other | Other | EUR 24,971.13 |
| 23.06.23 | None | Other | Buy | EUR 24,971.13 |
| 23.06.23 | None | Other | Buy | EUR 23,193.00 |
| 23.06.23 | None | Other | Buy | EUR 1,932.75 |
| 23.03.23 | None | Other | Sell | EUR 1,650,415.80 |
FR0013280286
LEI549300AK8Y0LBIQ4T071
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryCAC Next 20
Main Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.